Published date: 5 April 2017
This notice was replaced on 8 January 2018
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Early engagement (published 8 January 2018)
Closed early engagement
Contract summary
Industry
Antivirals for systemic use - 33651400
Location of contract
Any region
Procurement reference
CH/MP/2017
Published date
5 April 2017
Closing date
23 February 2018
Description
Arden & GEM CSU on behalf of the NHS England - Specialised Commissioning would like to notify all potential bidders about a 'Market Engagement Event' which has been planned to take place on Monday 24th April 2017.
This event has been arranged to provide information and seek feedback about the upcoming procurement of licensed tenofovir disoproxil/emtricitabine combined tablet formulations to meet the aims and objectives of the PrEP Impact Clinical trial.
To attend this event please email your organisation's and attendees' details to mark.perkins@nhs.net
Once you have confirmed your intention to attend, a briefing document will be provided including further details of the event, together with a short questionnaire to be completed and returned on or before the 19th April 2017.
The event will include a briefing for all potential suppliers as well as the opportunity for suppliers to meet individually with members of the NHS England and PHE PrEP Impact Trial team.
The event will be held in central London on Monday 24th April 2017.
About the buyer
Address
Cardinal Square, Nottingham Road
Derby
DE1 3QT
England
Share this notice
All content is available under the
